公司名稱:南京康佰生物科技有限公司
地址:南京市雨花區長虹路222號
郵編:
電話:025-86880024
手機: 18066071954
聯系人: 蔣
傳真:
E-mail: duhaitao@cobioer.com
地址:南京市雨花區長虹路222號
郵編:
電話:025-86880024
手機: 18066071954
聯系人: 蔣
傳真:
E-mail: duhaitao@cobioer.com
CBP60980NK92人惡性非霍奇金淋巴瘤患者的細胞的詳細資料:
NK92人惡性非霍奇金淋巴瘤患者的細胞
CBP60980 | |
I. General information | |
Synonyms: | NK92 |
Background: | NK-92 is an interleukin-2 IL-2 dependent Natural Killer Cell line derived from peripheral blood mononuclear cells from a 50 year old Caucasian male with rapidly progressive non-Hodgkin's lymphoma. |
Species: | Homo sapiens, human |
Tissue: | peripheral blood |
Disease: | malignant non-Hodgkin's lymphoma |
Gender: | male,50 years,Caucasian |
Morphology: | lymphoblast |
Growth Mode: | suspension, multicell aggregates |
DNA Profile: | Amelogenin: X,Y CSF1PO: 11,12 D13S317: 9,12 D16S539: 11,12 D5S818: 12,13 D7S820: 10,11 THO1: 6,9.3 TPOX: 8 vWA: 18 Cobioer’s Cell Line Authentication Service |
Culture Medium: | Alpha MEM without ribonucleosides and deoxyribonucleosides+2 mM Lglutamine+1.5 g/L sodium bicarbonate+0.2 mM inositol+0.1 mM 2-mercaptoethanol+0.02 mM folic acid+100-200 U/ml recombinant IL2+12.5% horse serum+12.5%FBS We strongly suggest to purchase the complete medium from Cobioer. |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | CD2 +, CD7 +, CD11a +, CD28 + , CD45 +, CD54 +, CD56 +, CD1 -, CD3 -, CD4 -, CD5 -, CD8 -, CD10 -, CD14 -, CD16 -, CD19 -, CD20 -, CD23 -, CD34 -, HLA-DR - |
Comments: | The cell line is dependent on the presence of recombinant Il-2 and a dose as low as 10 U/mL is sufficient to maintain proliferation; cells will die within 72 hours in the absence of IL-2. NK-92 cells have the following characteristics: surface marker positive for CD2, CD7, CD11a, CD28, CD45, CD54 and CD56 bright; surface marker negative for CD1, CD3, CD4, CD5, CD8, CD10, CD14, CD16, CD19, CD20, CD23, CD34 and HLA-DR. ATCC confirmed this cell line is positive for the presence of Epstein-Barr viral DNA sequences via PCR. For more information, please contact Cobioer 4008-750-250. |